Clinical Trials Logo

Primary Brain Tumors clinical trials

View clinical trials related to Primary Brain Tumors.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02568267 Active, not recruiting - Breast Cancer Clinical Trials

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

STARTRK-2
Start date: November 19, 2015
Phase: Phase 2
Study type: Interventional

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK gene fusion. Patients will be assigned to different baskets according to tumor type and gene fusion.